IGF1 and acromegaly: The subgroup of 11 patients with acromegaly who still had IGF-1 ≥ 1.3 ULN at 5 years post-surgery would, based on the consensus guidelines from 2023 [25, 26], still fulfil criteria for disease if symptoms were present.